Answers are grounded in this paper and cite their sources.
Among patients who had undergone mechanical ventilation for at least 3 days, a subsequent 3-day course of inhaled amikacin reduced the burden of ventilator-associated pneumonia during 28 days of follow-up. (Funded by the French Ministry of Health; AMIKINHAL ClinicalTrials.gov number, NCT03149640; EUDRA Clinical Trials number, 2016-001054-17.).
No takes yet. Share an insight, caveat, or question.
Ehrmann et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: